ACMT Position Statement: Buprenorphine Administration in the Emergency Department

被引：23
|
作者：
Wax, Paul M. [1 ]
Stolbach, Andrew I. [2 ]
Schwarz, Evan S. [3 ]
Warrick, Brandon J. [4 ]
Wiegand, Timothy J. [5 ]
Nelson, Lewis S. [6 ]
机构：
[1] Univ Texas Southwestern, Dallas, TX 75390 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA
[4] Univ New Mexico, Albuquerque, NM 87131 USA
[5] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[6] Rutgers New Jersey Med Sch, Newark, NJ USA
来源：
JOURNAL OF MEDICAL TOXICOLOGY | 2019年 / 15卷 / 03期
关键词：
Buprenorphine; Opioid use disorder; Emergency department; Opioid agonist therapy; MAT (medication-assisted therapy);
D O I：
10.1007/s13181-019-00712-3
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
[No abstract available]
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [21] ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic
    Farmer, Brenna M.
    Cole, Jon B.
    Olives, Travis D.
    Farrell, Natalija M.
    Rao, Rama
    Nelson, Lewis S.
    Mazer-Amirshahi, Maryann
    Stolbach, Andrew I.
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (04) : 481 - 483
  • [22] ACMT Position Statement: Institutions Housing Venomous Animals
    Seifert, Steven A.
    Keyler, Dan
    Isbister, Geoff
    McNally, Jude
    Martin, Thomas G.
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2006, 2 (03) : 118 - 119
  • [23] ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites
    Connors, Nicholas
    Kosnett, Michael J.
    Kulig, Ken
    Nelson, Lewis S.
    Stolbach, Andrew I.
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (02) : 240 - 242
  • [24] ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites
    Nicholas Connors
    Michael J. Kosnett
    Ken Kulig
    Lewis S. Nelson
    Andrew I. Stolbach
    [J]. Journal of Medical Toxicology, 2020, 16 : 240 - 242
  • [25] ACMT Position Statement: Addressing Pediatric Cannabis Exposure
    Amirshahi, Maryann Mazer
    Moss, Michael J.
    Smith, Silas W.
    Nelson, Lewis S.
    Stolbach, Andrew I.
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2019, 15 (03) : 212 - 214
  • [26] ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone
    Maryann Mazer-Amirshahi
    Andrew I. Stolbach
    Peggy Ye
    [J]. Journal of Medical Toxicology, 2023, 19 : 414 - 415
  • [27] ACMT Position Statement: End the Use of the Term "Excited Delirium"
    Stolbach, Andrew
    Dargan, Paul
    Greller, Howard
    Hamilton, Richard
    Johnson-Arbor, Kelly
    Murray, Brian Patrick J.
    Ovakim, Daniel T.
    Tormoehlen, Laura C.
    Nelson, Lewis
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 310 - 312
  • [28] ACMT position statement: the Iom report on thimerosal and autism.
    Kurt T.L.
    [J]. Journal of Medical Toxicology, 2006, 2 (4) : 170 - 171
  • [29] ACMT Position Statement: End the Use of the Term “Excited Delirium”
    Andrew I. Stolbach
    Paul I. Dargan
    Howard A. Greller
    Richard J. Hamilton
    Kelly Johnson-Arbor
    Brian Patrick Murray
    Daniel Ovakim
    Laura Tormoehlen
    Lewis S. Nelson
    [J]. Journal of Medical Toxicology, 2023, 19 : 310 - 312
  • [30] ACMT Position Statement: Interpretation of Urine Opiate and Opioid Tests
    Stolbach, Andrew
    Connors, Nicholas
    Nelson, Lewis
    Kulig, Ken
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2022, 18 (02) : 176 - 179
12345